Konferencje i webinary. Zamów newsletter. Zaloguj się. Zasady redakcyjne. Otwarty dostęp. Poleć ten artykuł:. Wyślij znajomemu. Skopiuj link:. Anna Woźniacka. Joanna Czuwara. Dorota Krasowska. Ewa Chlebus. Grażyna Wąsik. Anna Wojas-Pelc.
Lidia Rudnicka. Joanna Narbutt. Zygmunt Adamski. Rafał Czajkowski. Magdalena Czarnecka-Operacz. Iwona Flisiak. Cezary Kowalewski. Aleksandra Lesiak. Joanna Maj. Roman Nowicki. Agnieszka Owczarczyk-Saczonek. Małgorzata Olszewska. Witold Owczarek. Waldemar Placek. Adam Reich. Małgorzata Sokołowska-Wojdyło. Jacek Szepietowski. Anna Zalewska-Janowska. Barbara Zegarska. Metryki PlumX:. SKIN CARE In addition to prescribing an appropriate therapy for the acute disease phase, a fundamental task of physicians is to select effective drugs for the period of remission [1].
Specific recommendations concern lifestyle modifications, particularly proper diet, daily skin care, and photoprotection. Continuous comprehensive treatment greatly reduces the likelihood of relapse and also improves patient comfort [2—4]. A breakthrough in the approach to rosacea treatment came in , when the Rosacea International Expert Group ROSIE proposed a multifaceted strategy for the care of rosacea patients.
In addition to pharmacological and physical therapy, it encompasses an appropriate use of dermocosmetics for skin care and patient education, taking into consideration the psychological and social aspects of the disease [2].
The selection of effective skin care products is a challenging task because of widespread poor tolerability of many chemical compounds. The skin of rosacea sufferers is hypersensitive, dry, and prone to peeling and inflammatory reactions, erythematous and oedematous lesions accompanied by subjective complaints such as burning and stinging and, less commonly, pruritus [5, 6].
